Free Trial

Exponent, Inc. (NASDAQ:EXPO) Shares Purchased by Abacus FCF Advisors LLC

Exponent logo with Business Services background

Abacus FCF Advisors LLC increased its holdings in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 46.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,460 shares of the business services provider's stock after buying an additional 7,440 shares during the period. Abacus FCF Advisors LLC's holdings in Exponent were worth $2,090,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in EXPO. Private Trust Co. NA raised its position in Exponent by 129.8% during the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock worth $25,000 after acquiring an additional 157 shares during the last quarter. Atala Financial Inc purchased a new position in shares of Exponent during the 4th quarter worth approximately $25,000. Westside Investment Management Inc. acquired a new position in shares of Exponent during the 3rd quarter worth approximately $26,000. Tortoise Investment Management LLC lifted its stake in Exponent by 76.7% in the 4th quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after buying an additional 191 shares in the last quarter. Finally, Trust Co. of Vermont purchased a new stake in Exponent in the 4th quarter valued at approximately $45,000. 92.37% of the stock is owned by institutional investors and hedge funds.

Exponent Price Performance

Exponent stock traded up $1.32 during mid-day trading on Friday, hitting $80.32. 307,072 shares of the company were exchanged, compared to its average volume of 242,623. Exponent, Inc. has a 12-month low of $73.83 and a 12-month high of $115.75. The company has a market capitalization of $4.08 billion, a P/E ratio of 37.89 and a beta of 0.84. The business's 50 day simple moving average is $83.53 and its two-hundred day simple moving average is $93.12.

Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same quarter in the previous year, the firm posted $0.41 earnings per share. Equities research analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current year.

Insider Transactions at Exponent

In other news, VP Richard Reiss sold 1,736 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. This trade represents a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 2.10% of the company's stock.

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines